Interestingly, the immunomagnetic separation of the exosomes based on CD81 is not affected by the serum (even if it is undiluted), which can be easily detected by an electrochemical immunosensor using cancer related biomarkers, such as CD24 and CD340. This evidence concerns the gene ERBB2 and cancer.